BGM and CGM Market
BGM and CGM Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
BGM and CGM Market Size and Growth
The Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) market research reports indicate a growing demand for advanced diabetic management solutions. The BGM market is estimated to be worth $10 billion, while the CGM market is projected to reach $15 billion by 2025. Emerging technologies and increasing prevalence of diabetes are driving market growth. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ LifeScan
◍ Abbott
◍ Ascensia
◍ ARKRAY
◍ I-SENS
◍ Omron
◍ B. Braun
◍ 77 Elektronika
◍ AgaMatrix
◍ ALL Medicus
◍ Terumo
◍ Sinocare
◍ Yicheng
◍ Yuwell
◍ Acon
◍ Dexcom
◍ Medtronic
Competitive Landscape: Roche, LifeScan, Abbott, Ascensia, ARKRAY, I-SENS, Omron, B. Braun, 77 Elektronika, AgaMatrix, ALL Medicus, Terumo, Sinocare, Yicheng, Yuwell, Acon, Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated. These companies offer BGM and CGM devices and technologies to help patients monitor their blood glucose levels effectively, leading to market growth.
Sales Revenue Figures: Roche - $13.62 billion, Abbott$33.39 billion, Dexcom - $1.86 billion.
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
◍ BGM ◍ CGM ◍ Hospital ◍ Household
$ 2.50 Billion
Request Sample Report
Market Growth
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients